Details

Product number
6142501
CPT
-
Packaging group
6 x 500
Unit
ml
Composition
I) Glucoselösung 50 %: glucosum 77.5 g ut glucosum monohydricum 85.25 g, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 155 ml. II) Aminosäurenlösung 5.9% mit Elektrolyten: alaninum 1.03 g, argininum 1.08 g, acidum asparticum 0.77 g, cysteinum 0.24 g, acidum glutamicum 1.29 g, glycinum 0.51 g, histidinum 0.49 g, isoleucinum 0.86 g, leucinum 1.29 g, lysinum anhydricum 1.42 g ut lysinum monohydricum 1.59 g, methioninum 0.31 g, ornithinum 0.32 g ut ornithini hydrochloridum 0.41 g, phenylalaninum 0.54 g, prolinum 0.39 g, serinum 0.51 g, taurinum 0.08 g, threoninum 0.48 g, tryptophanum 0.26 g, tyrosinum 0.1 g, valinum 0.98 g, natrii chloridum 0.3 g, kalii acetas 1.12 g, calcii chloridum anhydricum 0.35 g ut calcii chloridum dihydricum 0.46 g, magnesii acetas 0.22 g ut magnesii acetas tetrahydricus 0.33 g, natrii glycerophosphas 0.69 g ut natrii glycerophosphas pentahydricus 0.98 g, acidum l-malicum, aqua ad iniectabile q.s. ad solutionem pro 221 ml. III) Fettemulsion 12.5%: olivae oleum et sojae oleum 15.5 g, phospholipida ex ovo ad iniectabile, glycerolum, natrii oleas, natrii hydroxidum, aqua ad iniectabile q.s. ad emulsionem pro 124 ml. I) et II) corresp.: nitrogenia 5.2 g/l, aminoacida 35 g/l, glucosum 206 g/l, natrium 31 mmol/l, kalium 30 mmol/l, magnesium 4.1 mmol/l, calcium 8.2 mmol/l, phosphas 8.5 mmol/l, acetas 39 mmol/l, l-malas 11 mmol/l, chloridum 37 mmol/l, in emulsione recenter mixta 1000 ml. Corresp. 960 kJ pro 1 l. I) et II) et III) corresp.: nitrogenia 3.9 g/l, aminoacida 26 g/l, glucosum 155 g/l, materia crassa 31 g/l, natrium 24 mmol/l, kalium 23 mmol/l, magnesium 3.1 mmol/l, calcium 6.2 mmol/l, phosphas 8.7 mmol/l, acetas 29 mmol/l, l-malas 8.6 mmol/l, chloridum 28 mmol/l, in emulsione recenter mixta 1000 ml. Corresp. 1030 kJ pro 1 l.

Articles (1)

Numeta Ped G16% E, Infusionslösung zur totalen parenteralen Ernährung
Infusionslösung zur totalen parenteralen Ernährung
6 x 500
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/08/2026
Professional SmPC
Français
13/08/2026
Professional SmPC
Italien
13/08/2026

Detailed composition

Substance Quantity Type Category
nitrogenia
3.9 GL Substance Wirkstoff (Principe actif)
glucosum
77.5 G Substance Wirkstoff (Principe actif)
olivae oleum
- Substance Wirkstoff (Principe actif)
nitrogenia
5.2 GL Substance Wirkstoff (Principe actif)
alaninum
1.03 G Substance Wirkstoff (Principe actif)
aminoacida
26.0 GL Substance Wirkstoff (Principe actif)
aminoacida
35.0 GL Substance Wirkstoff (Principe actif)
glucosum monohydricum
85.25 G Substance WIZUS
sojae oleum
15.5 G Substance Wirkstoff (Principe actif)
argininum
1.08 G Substance Wirkstoff (Principe actif)
acidum hydrochloridum
- Substance HNIDK
glucosum
155.0 GL Substance Wirkstoff (Principe actif)
acidum asparticum
0.77 G Substance Wirkstoff (Principe actif)
glucosum
206.0 GL Substance Wirkstoff (Principe actif)
phospholipida ex ovo ad iniectabile
- Substance HNIDK
natrium
31.0 MMOLL Substance Wirkstoff (Principe actif)
cysteinum
0.24 G Substance Wirkstoff (Principe actif)
glycerolum
- Substance HNIDK
materia crassa
31.0 GL Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
kalium
30.0 MMOLL Substance Wirkstoff (Principe actif)
acidum glutamicum
1.29 G Substance Wirkstoff (Principe actif)
natrium
24.0 MMOLL Substance Wirkstoff (Principe actif)
natrii oleas
- Substance HNIDK
magnesium
4.1 MMOLL Substance Wirkstoff (Principe actif)
kalium
23.0 MMOLL Substance Wirkstoff (Principe actif)
glycinum
0.51 G Substance Wirkstoff (Principe actif)
natrii hydroxidum
- Substance HNIDK
magnesium
3.1 MMOLL Substance Wirkstoff (Principe actif)
calcium
8.2 MMOLL Substance Wirkstoff (Principe actif)
histidinum
0.49 G Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
isoleucinum
0.86 G Substance Wirkstoff (Principe actif)
calcium
6.2 MMOLL Substance Wirkstoff (Principe actif)
phosphas
8.5 MMOLL Substance Wirkstoff (Principe actif)
phosphas
8.7 MMOLL Substance Wirkstoff (Principe actif)
leucinum
1.29 G Substance Wirkstoff (Principe actif)
acetas
39.0 MMOLL Substance Wirkstoff (Principe actif)
lysinum anhydricum
1.42 G Substance Wirkstoff (Principe actif)
acetas
29.0 MMOLL Substance Wirkstoff (Principe actif)
l-malas
11.0 MMOLL Substance Wirkstoff (Principe actif)
l-malas
8.6 MMOLL Substance Wirkstoff (Principe actif)
chloridum
37.0 MMOLL Substance Wirkstoff (Principe actif)
lysinum monohydricum
1.59 G Substance WIZUS
chloridum
28.0 MMOLL Substance Wirkstoff (Principe actif)
methioninum
0.31 G Substance Wirkstoff (Principe actif)
ornithinum
0.32 G Substance Wirkstoff (Principe actif)
ornithini hydrochloridum
0.41 G Substance WIZUS
phenylalaninum
0.54 G Substance Wirkstoff (Principe actif)
prolinum
0.39 G Substance Wirkstoff (Principe actif)
serinum
0.51 G Substance Wirkstoff (Principe actif)
taurinum
0.08 G Substance Wirkstoff (Principe actif)
threoninum
0.48 G Substance Wirkstoff (Principe actif)
tryptophanum
0.26 G Substance Wirkstoff (Principe actif)
tyrosinum
0.1 G Substance Wirkstoff (Principe actif)
valinum
0.98 G Substance Wirkstoff (Principe actif)
natrii chloridum
0.3 G Substance Wirkstoff (Principe actif)
kalii acetas
1.12 G Substance Wirkstoff (Principe actif)
calcii chloridum anhydricum
0.35 G Substance Wirkstoff (Principe actif)
calcii chloridum dihydricum
0.46 G Substance WIZUS
magnesii acetas
0.22 G Substance Wirkstoff (Principe actif)
magnesii acetas tetrahydricus
0.33 G Substance WIZUS
natrii glycerophosphas
0.69 G Substance Wirkstoff (Principe actif)
natrii glycerophosphas pentahydricus
0.98 G Substance WIZUS
acidum l-malicum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 659.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2023

Authorization holder

Baxter AG

8152 Opfikon

Authorization information

Swissmedic authorization number
61425
Drug name
Numeta Ped, Infusionslösung zur totalen parenteralen Ernährung
Galenic form
EMUI
ATC Code
B05BA10
Authorization status
Z
Dispensation category
B
First authorization
18/01/2012
Authorization expiration date
31/12/9999
IT number
07.01.2.
Domain
Human medicine
Field of application
Parenterale Ernährung

Packaging details

Description (FR)
NUMETA PED G16% E sol perf 6 sach 500 ml
Description (DE)
NUMETA PED G16% E Inf Lös 6 Btl 500 ml
Market launch
18/01/2012
Narcotic (BTM)
No

Other packaging sizes

NUMETA PED G19% E sol perf 6 x 1000 ml
6 x 1000 ML
View
Buy us a coffee Explore the data